Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Secures $7.5M in Revolving Credit

NEW YORK, Dec. 9 (GenomeWeb News) - Transgenomic said today that it has entered into an agreement for up to $7.5 million in a revolving line of credit with Laurus Master Fund.

Transgenomic said it would have access to the funds based on eligible accounts receivable and inventory balances. The arrangement replaces a previous $5.0 million line of credit from a commercial bank that had a higher interest rate, the company said.

Under the terms of the agreement, Transgenomic issued warrants to Laurus Funds to acquire up to 550,000 shares of its stock at a price based on a premium to the average trading price of its common stock for ten trading days prior to execution of the agreement.

In August, Transgenomic raised $4.5 million in a private placement with a number of investors.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.